Skip to main content
MGX logo

MGX · Metagenomi Therapeutics, Inc.

Track MGX — free
$1.17 +0.01 (+0.86%) At close · Sep 4
Market Cap
$44.20M
Shares
37.78M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1785279 CUSIP 59102M104 13F (30d) 40 filings 39 filers Visit website Investor relations